KushCo's common stock has ceased trading on the OTCQX effective as of the close of trading on August 31, 2021. Greenlane expects the Transaction to yield a number of important strategic synergies and financial benefits allowing for enhanced scale and rapid growth: Establishes the leading ancillary cannabis company delivering more value to customers across the supply chain: Greenlane serves a premier group of customers, including many of the leading multi-state-operators and licensed producers, the top smoke shops in the United States, and millions of consumers worldwide. Optimized platform with significant synergies: The Company expects to generate approximately $15 million to $20 million of annual run-rate cost synergies within 24 months from the closing of the Transaction. These synergies are expected to result from the economies of scale that will be realized following the Transaction, an optimized nationwide distribution network, and reduced operating expenses. Strengthens best-in-class proprietary brands and exclusive third-party brand offerings: As the leading supplier of premier consumer brands and products, Greenlane offers its customers a diversified and highly complementary product offering. Robust organic growth through cross-selling opportunities: the Company has the wide-ranging breadth of products and services needed to support the entire global cannabis industry. Unique ability to drive industry innovation and premier product design and development: With over 200 articles of Intellectual Property, the Company will cultivate a strong innovation pipeline across a broad category of product offerings, supported by an industry-leading and experienced product development and design team.
